NDC directory

RIVAROXABAN

rivaroxaban · Lifestar Pharma LLC · TABLET

70756-006ANDAFactor Xa Inhibitor [EPC]
Product NDC
70756-006
Generic name
rivaroxaban
Labeler name
Lifestar Pharma LLC
Brand name
RIVAROXABAN
Finished
true
Listing expiration date
20271231
Marketing category
ANDA
Dosage form
TABLET
SPL ID
0438bd24-fd5f-476b-a7e8-eeab15f3551b
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
70756-006_0438bd24-fd5f-476b-a7e8-eeab15f3551b
Application number
ANDA220874
Brand name base
RIVAROXABAN
Active ingredients
  1. Name
    RIVAROXABAN
    Strength
    2.5 mg/1
Packaging
  1. Package NDC
    70756-006-12
    Description
    1000 TABLET in 1 BOTTLE (70756-006-12)
    Marketing start date
    20261001
    Sample
    false
  2. Package NDC
    70756-006-60
    Description
    60 TABLET in 1 BOTTLE (70756-006-60)
    Marketing start date
    20261001
    Sample
    false
  3. Package NDC
    70756-006-81
    Description
    180 TABLET in 1 BOTTLE (70756-006-81)
    Marketing start date
    20261001
    Sample
    false
  4. Package NDC
    70756-006-99
    Description
    10 BLISTER PACK in 1 CARTON (70756-006-99) / 10 TABLET in 1 BLISTER PACK
    Marketing start date
    20261001
    Sample
    false
Route
ORAL
Pharm class
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.